DK129138B - Fremgangsmåde til fremstilling af tuberactinomycin-N. - Google Patents

Fremgangsmåde til fremstilling af tuberactinomycin-N.

Info

Publication number
DK129138B
DK129138B DK321671AA DK321671A DK129138B DK 129138 B DK129138 B DK 129138B DK 321671A A DK321671A A DK 321671AA DK 321671 A DK321671 A DK 321671A DK 129138 B DK129138 B DK 129138B
Authority
DK
Denmark
Prior art keywords
tuberactinomycin
preparation
Prior art date
Application number
DK321671AA
Other languages
Danish (da)
English (en)
Other versions
DK129138C (fr
Inventor
J Abe
T Watanabe
A Nagata
T Ando
T Take
R Izumi
T Noda
K Matsuura
Original Assignee
Toyo Jozo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo Kk filed Critical Toyo Jozo Kk
Publication of DK129138B publication Critical patent/DK129138B/da
Application granted granted Critical
Publication of DK129138C publication Critical patent/DK129138C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK321671AA 1970-06-30 1971-06-30 Fremgangsmåde til fremstilling af tuberactinomycin-N. DK129138B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45056467A JPS4838877B1 (fr) 1970-06-30 1970-06-30

Publications (2)

Publication Number Publication Date
DK129138B true DK129138B (da) 1974-08-26
DK129138C DK129138C (fr) 1975-01-13

Family

ID=13027895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK321671AA DK129138B (da) 1970-06-30 1971-06-30 Fremgangsmåde til fremstilling af tuberactinomycin-N.

Country Status (17)

Country Link
US (1) US3892732A (fr)
JP (1) JPS4838877B1 (fr)
AT (1) AT310944B (fr)
BE (1) BE769237A (fr)
CA (1) CA981198A (fr)
CH (1) CH558832A (fr)
CS (1) CS188875B2 (fr)
DE (1) DE2133181C3 (fr)
DK (1) DK129138B (fr)
ES (1) ES392755A1 (fr)
FR (1) FR2100846B1 (fr)
GB (1) GB1312541A (fr)
HU (1) HU164533B (fr)
NL (1) NL155049B (fr)
PL (1) PL81845B1 (fr)
SE (1) SE375324B (fr)
SU (1) SU384233A3 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
US4254224A (en) * 1979-03-12 1981-03-03 Merck & Co., Inc. Fermentation method for producing antibiotic A43F

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1613615B1 (de) * 1967-08-08 1970-07-02 Danfoss As Anlasseinrichtung fuer einen Einphasen-Asynchronmotor

Also Published As

Publication number Publication date
CA981198A (en) 1976-01-06
GB1312541A (en) 1973-04-04
DE2133181B2 (de) 1979-07-12
ES392755A1 (es) 1974-12-01
CS188875B2 (en) 1979-03-30
BE769237A (fr) 1971-11-03
DE2133181C3 (de) 1980-03-13
CH558832A (de) 1975-02-14
SU384233A3 (fr) 1973-05-23
AT310944B (de) 1973-10-25
US3892732A (en) 1975-07-01
FR2100846A1 (fr) 1972-03-24
PL81845B1 (fr) 1975-10-31
NL7109029A (fr) 1972-01-03
DE2133181A1 (de) 1972-02-10
DK129138C (fr) 1975-01-13
FR2100846B1 (fr) 1974-11-15
NL155049B (nl) 1977-11-15
HU164533B (fr) 1974-02-28
SE375324B (fr) 1975-04-14
JPS4838877B1 (fr) 1973-11-20

Similar Documents

Publication Publication Date Title
DK134601B (da) Analogifremgangsmåde til fremstilling af benzylimidazolidioner.
DK129339B (da) Analogifremgangsmåde til fremstilling af N-aminophenylamidiner.
DK135455B (da) Fremgangsmåde til fremstilling af 7-halogen-7-desoxythiolincosaminider.
DK140842B (da) Fremgangsmåde til fremstilling af 8,9-didebydro-10alfa-alkoxy-ergolener.
DK139576B (da) Fremgangsmåde til isolering af alfa-6-desoxy-5-oxytetracyklin.
DK134489B (da) Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider.
DK130467B (da) Fremgangsmåde til fremstilling af erythromycylaminer.
DK127977B (da) Fremgangsmåde til fremstilling af 6α-methyl-19-nor-pregnener.
DK126998B (da) Analogifremgangsmåde til fremstilling af amino-s-triazolylbenzensulfonamidforbindelser.
DK128205B (da) Fremgangsmåde til fremstilling af 1-aryloxy-2-propanoler.
DK129453B (da) Analogifremgangsmåde til fremstilling af 1-aminoisoquinoliner.
DK126323B (da) Fremgangsmåde til fremstilling af 3β-hydroxy-5α-cardenolider eller -bufadienolider.
DK137181B (da) Analogifremgangsmåde til fremstilling af 3-amino-kinolinderivater.
DK126509B (da) Fremgangsmåde til fremstilling af zearalenon.
DK138021B (da) Fremgangsmåde til fremstilling af aminopenicilliner.
DK127001B (da) Fremgangsmåde til fremstilling af alkylsilaner.
DK125388B (da) Fremgangsmåde til fremstilling af phenylaminoethanolderivater.
DK137860B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepin-5N-oxydderivater.
DK129788B (da) Analogifremgangsmåde til fremstilling af α-aminoalkyl-4-hydroxy-3-ureidobenzylalkoholer.
DK131786B (da) Fremgangsmåde til fremstilling af delta4-3-oxo-1alfa-methylsteroider.
DK129138B (da) Fremgangsmåde til fremstilling af tuberactinomycin-N.
DK127852B (da) Analogifremgangsmåde til fremstilling af 22-substituerede cardenolidrhamnosider.
DK127414B (da) Analogifremgangsmåde til fremstilling af phenylhydrazider.
DK128209B (da) Analogifremgangsmåde til fremstilling af 19-nor-14-dehydrotestosteronderivater.
DK129049B (da) Analogifremgangsmåde til fremstilling af α-aminobenzylpenicillinderivater.